Pure Global

Activity of Chronic Inflammation in PCOS - Trial NCT06300593

Access comprehensive clinical trial information for NCT06300593 through Pure Global AI's free database. This phase not specified trial is sponsored by Jagiellonian University and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06300593
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06300593
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Activity of Chronic Inflammation in PCOS
Evaluation of the Activity of Chronic Inflammation and Its Impact on Metabolic and Hormonal Parameters in Various PCOS Phenotypes

Study Focus

Polycystic Ovary Syndrome

Measurement and comparison of leucocytosis and concentrations of C-reactive protein (CRP), interleukin-1 (IL-1), IL-6, IL-10, Tumor Necrosis Factor (TNF-alpha) in PCOS phenotypes A, B, C and D

Observational

diagnostic test

Sponsor & Location

Jagiellonian University

Krakow, Poland

Timeline & Enrollment

N/A

Jan 15, 2024

Jun 30, 2024

80 participants

Primary Outcome

Values of inflammation parameters - leukocytosis in peripheral blood in the four PCOS phenotypes,Values of inflammation parameters - C-reactive protein (CRP) in peripheral blood in the four PCOS phenotypes,Values of inflammation parameters - IL-1 in peripheral blood in the four PCOS phenotypes,Values of inflammation parameters - IL-6 in peripheral blood in the four PCOS phenotypes,Values of inflammation parameters - IL-10 in peripheral blood in the four PCOS phenotypes,Values of inflammation parameters - TNF-alpha in peripheral blood in the four PCOS phenotypes

Summary

Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation
 of cytokine production (due to insulin resistance, excess visceral fat and
 hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6)
 in relation to anti-inflammatory ones (IL-10). This condition may be an important link
 between obesity and insulin resistance, which is crucial in the etiopathogenesis of the
 syndrome. However, it is not known whether it results from the tendency to accumulate adipose
 tissue or is a feature of the syndrome itself. There is no data indicating the relationship
 between chronic inflammation and the severity of metabolic disorders and the value of ovarian
 reserve in women with various PCOS phenotypes.

ICD-10 Classifications

Polycystic ovarian syndrome
Ovarian dysfunction, unspecified
Ovarian dysfunction
Other ovarian dysfunction
Neoplasm of uncertain or unknown behaviour: Ovary

Data Source

ClinicalTrials.gov

NCT06300593

Non-Device Trial